Verastem Oncology Reports Third Quarter 2019 Financial Results and Recent Company Progress

Go back to Verastem Oncology Reports Third Quarter 2019 Financial Results and Recent Company Progress
VERASTEM SHS (NASDAQ: VSTM) Delayed: 4.10 +0.16 (4.06%)
Previous Close $3.94    52 Week High $2.43 
Open $3.94    52 Week Low $1.05 
Day High $4.18    P/E N/A 
Day Low $3.94    EPS $-1.79 
Volume 1,600,049